Larry A. Barr, Ph.D. - Publications

Affiliations: 
2014 Physiology Temple University, Philadelphia, PA, United States 
Area:
Physiology Biology, Molecular Biology, Pharmacology

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Barr LA, Lambert JP, Shimizu Y, Barouch LA, Naqvi N, Calvert JW. Exercise training provides cardioprotection by activating and coupling endothelial nitric oxide synthase via a β3-adrenergic receptor-AMP-activated protein kinase signaling pathway. Medical Gas Research. 7: 1-8. PMID 28480026 DOI: 10.4103/2045-9912.202904  0.304
2016 Shimizu Y, Nicholson CK, Lambert JP, Barr LA, Kuek N, Herszenhaut D, Tan L, Murohara T, Hansen JM, Husain A, Naqvi N, Calvert JW. Sodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent Manner. Circulation. Heart Failure. 9. PMID 27056879 DOI: 10.1161/Circheartfailure.115.002368  0.436
2015 Barr LA, Shimizu Y, Lambert JP, Nicholson CK, Calvert JW. Hydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 46: 145-56. PMID 25575644 DOI: 10.1016/J.Niox.2014.12.013  0.388
2015 Shimizu Y, Nicholson CK, Lambert JP, Barr LA, Calvert JW. Hydrogen sulfide therapy attenuates the development of heart failure by increasing the activity of the proteasome in an Nrf2-dependent manner Nitric Oxide. 47: S25. DOI: 10.1016/J.Niox.2015.02.060  0.366
2014 Tilley DG, Zhu W, Myers VD, Barr LA, Gao E, Li X, Song J, Carter RL, Makarewich CA, Yu D, Troupes CD, Grisanti LA, Coleman RC, Koch WJ, Houser SR, et al. β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling. Circulation. 130: 1800-11. PMID 25205804 DOI: 10.1161/Circulationaha.114.010434  0.543
2014 Barr LA, Makarewich CA, Berretta RM, Gao H, Troupes CD, Woitek F, Recchia F, Kubo H, Force T, Houser SR. Imatinib activates pathological hypertrophy by altering myocyte calcium regulation. Clinical and Translational Science. 7: 360-7. PMID 24931551 DOI: 10.1111/Cts.12173  0.533
2012 Gao H, Wang F, Wang W, Makarewich CA, Zhang H, Kubo H, Berretta RM, Barr LA, Molkentin JD, Houser SR. Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling. Journal of Molecular and Cellular Cardiology. 53: 657-67. PMID 22921230 DOI: 10.1016/J.Yjmcc.2012.08.005  0.515
Show low-probability matches.